Prostaglandin E1 administration post liver transplantation and renal outcomes: A retrospective single center experience

Table 1 Baseline patient characteristics

Variable	PGE1 (n = 44)	Non-PGE1 (n = 101)	P value
Age (years; mean ± SD)	58 ± 11.9	56.7 ± 12.2	0.57
Male	54.6	61.4	0.44
White	84.1	83.2	0.78
Indication for transplant			0.3
Nonalcoholic fatty liver disease	31.8	28.7
Alcoholic liver disease	25	29.7
Hepatitis C virus infection	11.4	15.8
Others	31.8	25.8
Model for end-stage liver disease score at transplant	23.8 ± 10	25.2 ± 8	0.4
Hepatorenal syndrome pre-transplant	59.1	64.4	0.55

PGE1: Prostaglandin E1.